SCHEMBL4824084

SCHEMBL4824084

CN(CC1(CNC(=O)O)CC1)c1ccc(Cl)nc1

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.38
MEN1 O00255 2/20 0.38
ALDH1A1 P00352 2/20 0.38
LMNA P02545 1/20 0.38
LTC4S Q16873 3/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
NAPRT Q6XQN6 1/20 0.35
MAPT P10636 1/20 0.34
RAB9A P51151 3/20 0.34
SMN1; SMN2 Q16637 3/20 0.34
NPC1 O15118 1/20 0.34
P2RX7 Q99572 1/20 0.33
KCNQ3 O43525 1/20 0.32
KCNQ2 O43526 1/20 0.32
CYP2C9 P11712 1/20 0.32
NAMPT P43490 1/20 0.32
TP53 P04637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4820597 0.85 OPRM1 (0.32) LMNAP2RX7
SCHEMBL4823413 0.83 KMT2A (0.36) KMT2AMEN1ALDH1A1LMNALTC4S
SCHEMBL4818540 0.80 L3MBTL1 (0.39) KMT2AMEN1ALDH1A1LMNAL3MBTL1
SCHEMBL4824592 0.80 L3MBTL1 (0.42) KMT2AMEN1ALDH1A1LMNALTC4S
SCHEMBL3141921 0.80 KMT2A (0.32) KMT2AALDH1A1LMNALTC4SP2RX7
SCHEMBL4824088 0.77 MEN1 (0.39) KMT2AMEN1ALDH1A1LMNALTC4S
SCHEMBL4818188 0.75 KCNQ3 (0.43) ALDH1A1L3MBTL1NAPRTRAB9ASMN1; SMN2
SCHEMBL4669089 0.74 POLB (0.35) KMT2AMEN1ALDH1A1LMNAMAPT
SCHEMBL4672795 0.73 MEN1 (0.34) KMT2AMEN1ALDH1A1LMNA
SCHEMBL3151458 0.73 ABL1 (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080146621-A1 Polysubstituted 1,1-pyridylaminocyclopropanamine compounds LES LABORATORIES SERVIER (FR) 2008-06-19 US disclosed
US-7388022-B2 Polysubstituted 1,1-pyridylaminocyclopropanamine compounds LES LABORATOIRES SERVIER (FR) 2008-06-17 US disclosed
US-20070027192-A1 Polysubstituted 1,1-pyridylamioncyclopropanamine compounds LES LABORATOIRES SERVIER (FR) 2007-02-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080146621-A1 Polysubstituted 1,1-pyridylaminocyclopropanamine compounds CHRNA1, CHRM1, CHRNA9 KMT2A 2105/4885MEN1 3199/4885ALDH1A1 531/4885
US-20070027192-A1 Polysubstituted 1,1-pyridylamioncyclopropanamine compounds CHRM1, CHRM2, CHRM3 KMT2A 2287/4885MEN1 2023/4885ALDH1A1 747/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.